Evidence map›Paper›PMID 33898259›Full record

ArticleIDCases2021

Effectiveness of daptomycin against infective endocarditis caused by highly penicillin-resistant viridans group streptococci.

Takahiro Matsuo, Nobuyoshi Mori, Aki Sakurai, Takayoshi Kanie, Yumiko Mikami, Yuki Uehara, Keiichi Furukawa

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in IDCases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Takahiro MatsuoDepartment of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan.
Nobuyoshi MoriDepartment of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan.
Aki SakuraiDepartment of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan.
Takayoshi KanieDepartment of Cardiology, St. Luke's International Hospital, Tokyo, Japan.
Yumiko MikamiDepartment of Clinical Laboratory, St. Luke's International Hospital, Tokyo, Japan.
Yuki UeharaDepartment of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan.
Keiichi FurukawaDepartment of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan.
St. Luke's International Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Penicillin-resistant viridans group streptococci (VGS) infections are an emerging issue in infectious diseases. Here, we present a case of mitral valve infective endocarditis caused by highly penicillin-resistant VGS (minimum inhibitory concentration >4 μg/mL), which was successfully treated with daptomycin. Although the clinical efficacy of daptomycin has not been established, it can be an alternative for the treatment of highly resistant VGS endocarditis.

Indexed as

DaptomycinInfective endocarditisPenicillin-resistant viridans group streptococci

Identifiers

PMID33898259
PMCPMC8055607
OpenAlexW3146288378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.